A Prospective Multi-Center Research on Bowel Dysfunction After Sphincter Preservative Surgery (PMCRBDSPS)

January 2, 2017 updated by: Peking University People's Hospital

A Prospective, Randomization and Clinic Cohort Observational Study From Multi Institutions on Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation

This research plans to collect rectal cancer patients after sphincter-preserving surgery from 14 institutions in China mainland, observe the incidence and risk factors about bowel dysfunction after operation.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

460

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Rectal cancer patients who accept sphincter-preserving surgery

Description

Inclusion Criteria:

  1. Age ≥ 18 years
  2. Adenocarcinoma confirmed by pathology
  3. Distance from the lowest margin of tumor to the anal verge is ≤ 12cm, confirmed by hard sigmoidoscope.
  4. The tumor is estimated to be resectable and confirmed by multidisciplinary team (MDT).
  5. The operation is estimated to be sphincter-preserving.
  6. The Eastern Cooperative Oncology Group(ECOG) performance status score of patient is ≤ 2.
  7. The estimated life time is not less than one year.
  8. The patient agree to sign the informed consent.

Exclusion Criteria:

  1. The patient refuse to follow research plan.
  2. Emergency case
  3. Pregnant and lactating female patient
  4. The patient did not accept radical resection.
  5. The patient did not accept first stage resection and anastomosis.
  6. The patient has experienced anal-rectal surgery.
  7. The patient has experienced left colon surgery.
  8. The patient suffered long-existing bowel dysfunction before rectal cancer diagnosis.
  9. The patient was diagnosed with cognitive or communicative obstacles.
  10. The patient was diagnosed with serious repeated infection or other concomitance diseases.
  11. The patient has participated other medical research which may affect his/her bowel function.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
sphincter-preserving surgery
Patients meet the inclusion criteria will be enrolled into this observing group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of bowel dysfunction after sphincter-preserving surgery
Time Frame: one year
one year
Risk factors of bowel dysfunction after sphincter-preserving surgery
Time Frame: one year
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of each symptoms of bowel dysfunction
Time Frame: one year
one year
Prognosis of bowel dysfunction after sphincter-preserving surgery
Time Frame: one year
one year
Incidence of bowel dysfunction after sphincter-preserving surgery
Time Frame: one year
comparing incidences between high and low anastomsis site
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2017

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

January 2, 2017

First Submitted That Met QC Criteria

January 2, 2017

First Posted (Estimate)

January 4, 2017

Study Record Updates

Last Update Posted (Estimate)

January 4, 2017

Last Update Submitted That Met QC Criteria

January 2, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectal Cancer

3
Subscribe